GLMD · Galmed Pharmaceuticals Ltd.
$0.52
+0.00 (+0.00%)
At close · Aug 17
Market Cap
$4.24M
Shares
8.26M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
FY2020
Net Income
-$10.31M
-37.1%
FY2025
Operating Margin
-525.76%
+613.8pp
FY2018
Diluted EPS
$2.39
-70.4%
FY2025
Operating Cash Flow
-$6.32M
-7.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | $0 | $0 | $2.04M | $1.09M | $467K | $0 | $0 | — | — | |
| $4.87M | $2.98M | $3.57M | $13M | $27.22M | $26.08M | $18.18M | $8.31M | $9.65M | $14.27M | $7.63M | $6.66M | $7.21M | $2.44M | |
| $3.64M | $3.3M | $3.92M | $4.66M | $5.66M | $4.13M | $4.2M | $4.44M | $3.8M | $3.08M | $3.25M | $2.48M | $7.36M | $694K | |
| — | $83K | $31K | $35K | $42K | $39K | $35K | $387K | $239K | $169K | $50K | $9000 | $4000 | $5000 | |
| $8.51M | $6.28M | $7.49M | $17.65M | $32.88M | $30.21M | $22.38M | $10.72M | $12.36M | $16.88M | $10.88M | $9.14M | $14.57M | $3.14M | |
| — | — | — | — | — | -$30.21M | -$22.38M | -$10.72M | -$12.36M | — | — | — | — | — | |
| — | — | — | — | — | — | — | -525.76% | -1139.54% | — | — | — | — | — | |
| — | — | — | — | — | -$30.17M | -$22.34M | -$10.33M | -$12.13M | — | — | — | — | — | |
| -$741K | -$516K | -$580K | -$215K | $414K | $1.44M | -$1.92M | $934K | $65K | $35K | $253K | $40K | -$2.91M | -$6000 | |
| — | $7000 | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | $7.52M | $6.91M | $17.87M | -$32.47M | -$28.77M | -$20.46M | -$9.78M | -$12.3M | -$16.85M | -$10.62M | -$9.1M | -$17.48M | -$3.14M | |
| $0 | — | — | — | — | $0 | $0 | $75K | $0 | $106K | $0 | $1000 | $1000 | $6000 | |
| -$10.31M | -$7.52M | -$6.91M | -$17.87M | -$32.47M | -$28.77M | -$20.46M | -$9.86M | -$12.3M | -$16.95M | -$10.62M | -$9.1M | -$17.49M | -$3.15M | |
| — | — | — | — | — | — | — | -483.61% | -1133.55% | -3630.19% | — | — | — | — | |
| — | — | — | — | — | -$28.53M | -$20.42M | -$9.86M | -$12.22M | -$16.83M | -$10.83M | -$9.1M | -$17.49M | -$3.15M | |
| USD/shares | $2.39 | $8.08 | $30.00 | $127.80 | $237.60 | $243.00 | $174.60 | — | — | — | — | — | — | — |
| USD/shares | $2.39 | $8.08 | $30.00 | $127.80 | $237.60 | — | — | — | — | — | — | — | — | — |
| shares | 4.31M | 930.82K | 230.8K | 139.68K | 136.65K | 118.23K | 117.3K | 100.76K | 69.37K | 63.19K | 61.67K | 57.35K | 28.16K | 27.53K |
| shares | 4.31M | 930.82K | 230.8K | 139.68K | 136.65K | 118.23K | 117.3K | 100.76K | 69.37K | 63.19K | 61.67K | 57.35K | 28.16K | 27.53K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Key facts
CIK
1595353
CUSIP
M47238148
13F (30d)
13 filings
13 filers
Visit website
Investor relations